1·Stratification variables included presence of extra hepatic disease (EHD;
分层变量包括额外的肝脏疾病存在（EHD；
2·No other complications such as heart disease, hepatic disease and renal disease.
无严重心、脑、肝、肾疾病及其他严重的躯体疾病；
3·Incidence of hepatic disease caused by drugs is increasing since drug species are more.
随着药物种类的增多，药物性肝病的发病率亦增加。
4·There are probably several factors responsible for water and salt retention and ascites in hepatic disease.
引起肝病患者水、盐潴留和腹水的原因可能不止一个。
5·OBJECTIVE: To observe curative effect of Meineng injection in the treatment of pregnancy associated with hepatic disease.
目的：观察美能注射剂治疗妊娠合并肝病的疗效。
6·CONCLUSION: Meineng injection can be used safely and effectively for the treatment of pregnancy associated with hepatic disease.
结论：美能注射剂能安全、有效地治疗妊娠合并肝病。
7·Objective To study and analyze the significance of the changes of plasma level of neuropeptide (NPY) in the patients with chronic hepatic disease.
目的：观察慢性肝脏疾病患者血浆神经肽y (npy)水平变化及其与病变程度和预后的关系。
8·We examined 68 patients with chronic hepatic disease and 30 healthy persons by RIAin order to discuss the relationship between the EDF and chronic hepatic disease.
本文应用放免法检测68例慢性肝病患者及30例健康人的血清EDF，旨在探讨EDF与慢性肝病的关系。
9·Concomitant use of corticosteroids may increase fluid retention and should be monitored cautiously, particularly in patients with cardiac, renal, or hepatic disease.
同时使用皮质激素类药物可能会增加液体潴留，故应进行仔细地监测，特别是在伴有心脏、肾脏或肝脏疾病的患者中。
10·Therefore, the synthetic action of local pro-inflammatory and anti-inflammatory responses should be taken into account in the treatment of endotoxin-induced hepatic disease.
因此，在内毒素肝损伤的防治中应考虑到局部抗炎与致炎反应的综合作用。